PRESS RELEASE published on 09/01/2026 at 18:00, 2 months 18 days ago BIOSYNEX SA: Départ de Monsieur Thierry Paper Départ de Monsieur Thierry Paper, co-fondateur de BIOSYNEX, de ses fonctions opérationnelles. Larry Abensur remercie Thierry Paper pour sa contribution au développement de la Société Départ BIOSYNEX Larry Abensur Thierry Paper Laboratoire Français
BRIEF published on 08/06/2026 at 18:20, 3 months 13 days ago BIOSYNEX SA victime d'une cyberattaque Santé Sécurité Données BIOSYNEX Cyberattaque
BRIEF published on 08/06/2026 at 18:20, 3 months 13 days ago BIOSYNEX SA victim of a cyberattack Security Data Cyberattack Health BIOSYNEX
PRESS RELEASE published on 08/06/2026 at 18:15, 3 months 13 days ago BIOSYNEX SA: Cyberattaque BIOSYNEX SA annonce avoir été victime d'une cyberattaque, prenant des mesures pour limiter l'impact et renforcer la sécurité. Aucune conséquence sur l'opérationnel. Enquête en cours Enquête Sécurité Cyberattaque BIOSYNEX SA Laboratoire
BRIEF published on 07/22/2026 at 18:05, 3 months 28 days ago Chiffre d'affaires semestriel de BIOSYNEX en baisse Chiffre D'affaires BIOSYNEX Division Pharmacie Division Diagnostic Rééchelonnement De La Dette
BRIEF published on 07/22/2026 at 18:05, 3 months 28 days ago BIOSYNEX's half-year revenue is down Revenue BIOSYNEX Pharmacy Division Diagnostic Division Debt Rescheduling
PRESS RELEASE published on 07/22/2026 at 18:00, 3 months 28 days ago BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2026 : 44,1 M€ - PERSPECTIVES Biosynex SA annonce un chiffre d'affaires de 44,1 M€ au 1er semestre 2026 avec des perspectives de rééchelonnement de dette et nouveaux marchés Chiffre D'affaires Perspectives BIOSYNEX SA 1er Semestre 2026 Rééchelonnement Dette
BRIEF published on 06/11/2026 at 07:05, 5 months 9 days ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 5 months 9 days ago Biosynex finalise la cession de son activité de biologie moléculaire Cession Restructuration BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 5 months 9 days ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
Published on 11/20/2026 at 14:50, 49 minutes ago Proposed Issue Of Payment-In-Kind Interest Shares Under Convertible Debenture
Published on 11/20/2026 at 14:00, 1 hour 39 minutes ago Dateline appoints Tony Ferguson as Acting Chairman
Published on 11/20/2026 at 13:30, 2 hours 9 minutes ago Collective Metals Enters Into Option to Acquire the Lac Tio West Property in Quebec
Published on 11/20/2026 at 13:30, 2 hours 9 minutes ago Alset AI Closes Non-Brokered Private Placement Offering
Published on 11/20/2026 at 15:21, 18 minutes ago Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
Published on 11/20/2026 at 15:03, 35 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle PLC
Published on 11/19/2026 at 19:00, 20 hours 39 minutes ago MR.BRICOLAGE: OUTLOOK FOR THE 2026 FINANCIAL YEAR
Published on 11/19/2026 at 19:00, 20 hours 39 minutes ago MR.BRICOLAGE : PERSPECTIVES POUR L'EXERCICE 2026
Published on 11/19/2026 at 08:30, 1 day 7 hours ago Data sovereignty: Cegedim opens EB6, a next-generation datacenter for AI and high-density computing
Published on 11/19/2026 at 08:30, 1 day 7 hours ago Souveraineté des données : Cegedim ouvre EB6, un datacenter nouvelle génération pour l'IA et la haute densité